Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt 30.35
PDEX's Cash-to-Debt is ranked higher than
70% of the 189 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.62 vs. PDEX: 30.35 )
Ranked among companies with meaningful Cash-to-Debt only.
PDEX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 1.12 Max: No Debt
Current: 30.35
Equity-to-Asset 0.84
PDEX's Equity-to-Asset is ranked higher than
82% of the 184 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.58 vs. PDEX: 0.84 )
Ranked among companies with meaningful Equity-to-Asset only.
PDEX' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.05  Med: 0.69 Max: 0.9
Current: 0.84
0.05
0.9
Interest Coverage 167.18
PDEX's Interest Coverage is ranked higher than
50% of the 133 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 45.06 vs. PDEX: 167.18 )
Ranked among companies with meaningful Interest Coverage only.
PDEX' s Interest Coverage Range Over the Past 10 Years
Min: 2.52  Med: 8.43 Max: 23.5
Current: 167.18
2.52
23.5
Piotroski F-Score: 7
Altman Z-Score: 7.80
Beneish M-Score: -0.59
WACC vs ROIC
2.69%
48.95%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 4/10

vs
industry
vs
history
Operating Margin % 8.14
PDEX's Operating Margin % is ranked lower than
52% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.86 vs. PDEX: 8.14 )
Ranked among companies with meaningful Operating Margin % only.
PDEX' s Operating Margin % Range Over the Past 10 Years
Min: -15.47  Med: -6.9 Max: 14.46
Current: 8.14
-15.47
14.46
Net Margin % 20.17
PDEX's Net Margin % is ranked higher than
92% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.79 vs. PDEX: 20.17 )
Ranked among companies with meaningful Net Margin % only.
PDEX' s Net Margin % Range Over the Past 10 Years
Min: -14.56  Med: -3.62 Max: 10.97
Current: 20.17
-14.56
10.97
ROE % 43.56
PDEX's ROE % is ranked higher than
96% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.30 vs. PDEX: 43.56 )
Ranked among companies with meaningful ROE % only.
PDEX' s ROE % Range Over the Past 10 Years
Min: -32.8  Med: -4.91 Max: 29.43
Current: 43.56
-32.8
29.43
ROA % 35.05
PDEX's ROA % is ranked higher than
99% of the 191 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.23 vs. PDEX: 35.05 )
Ranked among companies with meaningful ROA % only.
PDEX' s ROA % Range Over the Past 10 Years
Min: -19.31  Med: -3.7 Max: 17.69
Current: 35.05
-19.31
17.69
ROC (Joel Greenblatt) % 28.24
PDEX's ROC (Joel Greenblatt) % is ranked higher than
62% of the 190 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.88 vs. PDEX: 28.24 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
PDEX' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -37.62  Med: -10.6 Max: 48.81
Current: 28.24
-37.62
48.81
3-Year Revenue Growth Rate 9.40
PDEX's 3-Year Revenue Growth Rate is ranked higher than
72% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.10 vs. PDEX: 9.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
PDEX' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -25.7  Med: -1.2 Max: 20.9
Current: 9.4
-25.7
20.9
GuruFocus has detected 4 Warning Signs with Pro-Dex Inc $PDEX.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» PDEX's 30-Y Financials

Financials (Next Earnings Date: 2017-09-15 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with PDEX

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies    NAICS: 339112    SIC: 3841
Compare:OTCPK:LDSYF, NAS:BMRA, NAS:ATEC, AMEX:DXR, NAS:CASM, NAS:EKSO, OTCBB:NEPH, NAS:BLFS, OTCPK:ERGVF, OTCPK:REPR, AMEX:ISR, OTCPK:IGAP, NAS:AKER, OTCPK:STXS, OTCPK:UEEC, AMEX:INFU, NAS:VLRX, AMEX:RVP, NAS:SKLN, OTCPK:VPTDF » details
Traded in other countries:PDXN.Germany,
Headquarter Location:USA
Pro-Dex Inc with operations in designs and produces powered surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries.

Pro-Dex Inc was incorporated in the State of Colorado. The Company with operations in Irvine, California and Beaverton, Oregon, designs and produces powered surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Companys products are found in hospitals, dental offices, medical engineering labs, commercial and military aircraft, scientific research facilities and high-tech manufacturing operations internationally. The names Micro Motors, Oregon Micro Systems, and Astromec are used for marketing purposes as brand names. The Companys medical device products utilize under development and supply agreements and are manufactured in Irvine, California facility, as are its dental products. Its medical device products are sold mainly to original equipment manufacturers and its dental products are sold mainly to dental product distributors. In its Beaverton, Oregon facility, it designs and manufactures embedded multi-axis motion controllers which are sold to distributors or original equipment manufacturers in the automation and research industries. The Company competes in all of its markets with other medical device and motion control related companies. As a provider of outsourced services, it also competes with its customers own internal development and manufacturing groups. The manufacture and distribution of medical and dental devices are subject to state and federal requirements set forth by various agencies including state dental boards and the U.S. Food and Drug Administration.

Ratios

vs
industry
vs
history
PE Ratio 5.11
PDEX's PE Ratio is ranked higher than
97% of the 118 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.48 vs. PDEX: 5.11 )
Ranked among companies with meaningful PE Ratio only.
PDEX' s PE Ratio Range Over the Past 10 Years
Min: 2.06  Med: 18 Max: 67
Current: 5.11
2.06
67
PE Ratio without NRI 5.78
PDEX's PE Ratio without NRI is ranked higher than
97% of the 119 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 31.38 vs. PDEX: 5.78 )
Ranked among companies with meaningful PE Ratio without NRI only.
PDEX' s PE Ratio without NRI Range Over the Past 10 Years
Min: 2.19  Med: 18.17 Max: 67
Current: 5.78
2.19
67
Price-to-Owner-Earnings 4.13
PDEX's Price-to-Owner-Earnings is ranked higher than
97% of the 80 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.93 vs. PDEX: 4.13 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
PDEX' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 2.16  Med: 8.9 Max: 66.59
Current: 4.13
2.16
66.59
PB Ratio 1.77
PDEX's PB Ratio is ranked higher than
80% of the 181 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.56 vs. PDEX: 1.77 )
Ranked among companies with meaningful PB Ratio only.
PDEX' s PB Ratio Range Over the Past 10 Years
Min: 0.27  Med: 0.94 Max: 2.67
Current: 1.77
0.27
2.67
PS Ratio 1.04
PDEX's PS Ratio is ranked higher than
83% of the 180 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.01 vs. PDEX: 1.04 )
Ranked among companies with meaningful PS Ratio only.
PDEX' s PS Ratio Range Over the Past 10 Years
Min: 0.15  Med: 0.58 Max: 1.2
Current: 1.04
0.15
1.2
Price-to-Free-Cash-Flow 8.98
PDEX's Price-to-Free-Cash-Flow is ranked higher than
71% of the 73 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.88 vs. PDEX: 8.98 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
PDEX' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 1.41  Med: 5.25 Max: 195.33
Current: 8.98
1.41
195.33
Price-to-Operating-Cash-Flow 6.89
PDEX's Price-to-Operating-Cash-Flow is ranked higher than
74% of the 95 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 19.90 vs. PDEX: 6.89 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
PDEX' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 1.33  Med: 5.54 Max: 372
Current: 6.89
1.33
372
EV-to-EBIT 10.25
PDEX's EV-to-EBIT is ranked higher than
82% of the 194 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 24.30 vs. PDEX: 10.25 )
Ranked among companies with meaningful EV-to-EBIT only.
PDEX' s EV-to-EBIT Range Over the Past 10 Years
Min: -73.1  Med: -1.8 Max: 35.6
Current: 10.25
-73.1
35.6
EV-to-EBITDA 7.91
PDEX's EV-to-EBITDA is ranked higher than
85% of the 203 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.15 vs. PDEX: 7.91 )
Ranked among companies with meaningful EV-to-EBITDA only.
PDEX' s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.4  Med: 2 Max: 271.9
Current: 7.91
-27.4
271.9
Current Ratio 4.74
PDEX's Current Ratio is ranked higher than
72% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.54 vs. PDEX: 4.74 )
Ranked among companies with meaningful Current Ratio only.
PDEX' s Current Ratio Range Over the Past 10 Years
Min: 0.7  Med: 3.13 Max: 8.5
Current: 4.74
0.7
8.5
Quick Ratio 3.48
PDEX's Quick Ratio is ranked higher than
70% of the 187 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.67 vs. PDEX: 3.48 )
Ranked among companies with meaningful Quick Ratio only.
PDEX' s Quick Ratio Range Over the Past 10 Years
Min: 0.33  Med: 1.85 Max: 7.5
Current: 3.48
0.33
7.5
Days Inventory 81.80
PDEX's Days Inventory is ranked higher than
69% of the 175 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 124.79 vs. PDEX: 81.80 )
Ranked among companies with meaningful Days Inventory only.
PDEX' s Days Inventory Range Over the Past 10 Years
Min: 81.04  Med: 106.19 Max: 149.66
Current: 81.8
81.04
149.66
Days Sales Outstanding 62.78
PDEX's Days Sales Outstanding is ranked higher than
96% of the 153 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 61.76 vs. PDEX: 62.78 )
Ranked among companies with meaningful Days Sales Outstanding only.
PDEX' s Days Sales Outstanding Range Over the Past 10 Years
Min: 26.6  Med: 42.82 Max: 63.44
Current: 62.78
26.6
63.44
Days Payable 22.35
PDEX's Days Payable is ranked lower than
94% of the 145 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 53.53 vs. PDEX: 22.35 )
Ranked among companies with meaningful Days Payable only.
PDEX' s Days Payable Range Over the Past 10 Years
Min: 19.51  Med: 31.55 Max: 70.41
Current: 22.35
19.51
70.41

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -6.50
PDEX's 3-Year Average Share Buyback Ratio is ranked lower than
62% of the 120 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -3.20 vs. PDEX: -6.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
PDEX' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -55.1  Med: -3.1 Max: 0.9
Current: -6.5
-55.1
0.9

Valuation & Return

vs
industry
vs
history
Price-to-Net-Cash 14.30
PDEX's Price-to-Net-Cash is ranked lower than
99.99% of the 48 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 17.17 vs. PDEX: 14.30 )
Ranked among companies with meaningful Price-to-Net-Cash only.
PDEX' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 7.81  Med: 20.82 Max: 556
Current: 14.3
7.81
556
Price-to-Net-Current-Asset-Value 2.62
PDEX's Price-to-Net-Current-Asset-Value is ranked higher than
89% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.18 vs. PDEX: 2.62 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
PDEX' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.9  Med: 3.05 Max: 72.3
Current: 2.62
0.9
72.3
Price-to-Tangible-Book 1.83
PDEX's Price-to-Tangible-Book is ranked higher than
85% of the 154 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.77 vs. PDEX: 1.83 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
PDEX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.46  Med: 2.17 Max: 16.38
Current: 1.83
0.46
16.38
Price-to-Intrinsic-Value-Projected-FCF 2.52
PDEX's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
54% of the 82 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.03 vs. PDEX: 2.52 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
PDEX' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.33  Med: 1.71 Max: 5.78
Current: 2.52
0.33
5.78
Price-to-Median-PS-Value 1.79
PDEX's Price-to-Median-PS-Value is ranked lower than
74% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.14 vs. PDEX: 1.79 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
PDEX' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.24  Med: 1.28 Max: 4.12
Current: 1.79
0.24
4.12
Price-to-Graham-Number 0.68
PDEX's Price-to-Graham-Number is ranked higher than
98% of the 87 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.67 vs. PDEX: 0.68 )
Ranked among companies with meaningful Price-to-Graham-Number only.
PDEX' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.26  Med: 1.62 Max: 8.09
Current: 0.68
0.26
8.09
Earnings Yield (Greenblatt) % 9.76
PDEX's Earnings Yield (Greenblatt) % is ranked higher than
86% of the 267 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.18 vs. PDEX: 9.76 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
PDEX' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.8  Med: 7.2 Max: 183.6
Current: 9.76
2.8
183.6
Forward Rate of Return (Yacktman) % -27.38
PDEX's Forward Rate of Return (Yacktman) % is ranked lower than
98% of the 90 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. PDEX: -27.38 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
PDEX' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -26.4  Med: 8.55 Max: 25
Current: -27.38
-26.4
25

More Statistics

Revenue (TTM) (Mil) $22.59
EPS (TTM) $ 1.12
Beta0.05
Short Percentage of Float0.09%
52-Week Range $3.77 - 6.68
Shares Outstanding (Mil)4.01
» More Articles for PDEX

Headlines

Articles On GuruFocus.com
Bsquare and Pro-Dex Improved Financial Performance; Avon Products Fakes Bid May 15 2015 
Incentives matter: Pro-Dex (PDEX) Oct 10 2013 
BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 
Pro-Dex Inc: Are Stories Of Its Death Greatly Exaggerated? Dec 12 2011 
ProDex Inc. Reports Operating Results (10-Q) Feb 10 2011 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 23,946 Shares Nov 06 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 15,000 Shares Nov 04 2009 
ProDex Inc. Reports Operating Results (10-K) Sep 17 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 28,000 Shares Jun 11 2009 
ProDex Inc. (PDEX) CEO Mark Phillip Murphy buys 19,504 Shares Jun 04 2009 

More From Other Websites
Pro-Dex, Inc. Announces Fiscal 2017 Third Quarter and Nine-Month Results May 11 2017
ETFs with exposure to Pro-Dex, Inc. : April 7, 2017 Apr 07 2017
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: Q2, 2017 By the Numbers : March 15, 2017 Mar 15 2017
Pro-Dex, Inc. Announces Fiscal 2017 Second Quarter And Six-Month Results Feb 09 2017
Pro-Dex, Inc. Announces Sale of OMS Division Jan 30 2017
Pro-Dex, Inc. Announces Top Workplace Recognition and Placement as a Fastest Growing Orange County... Dec 13 2016
ETFs with exposure to Pro-Dex, Inc. : December 13, 2016 Dec 13 2016
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: Q1, 2017 By the Numbers : November 14, 2016 Nov 14 2016
Pro-Dex, Inc. Announces Fiscal 2017 First Quarter Results Nov 10 2016
Pro-Dex, Inc.: Strong price momentum but will it sustain? Oct 10 2016
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: 2016 By the Numbers : September 20, 2016 Sep 20 2016
Pro-Dex, Inc. Announces Fiscal 2016 Fourth Quarter and Full-Year Results Sep 15 2016
Pro-Dex, Inc. :PDEX-US: Earnings Analysis: Q3, 2016 By the Numbers May 19 2016
4 Stocks That are Trading With Heavy Volume Today Feb 12 2016
Pro-Dex, Inc. Earnings Q1, 2016 Dec 01 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)